Therefore, IL-6 is a biomarker to predict COVID-19 severity, and also fatal outcomes both in the general SARS-CoV-2 infected population and in COVID-19 patients with obesity. The gene discussed is IL6; the disease is obesity due to melanocortin 4 receptor deficiency.